Free ASCP MLS Exam Flashcards

The MLS exam is a 100-question computer adaptive test with a 2-hour-30-minute time limit. Each item is one-best-answer multiple choice, so practice should focus on choosing the most defensible answer.

CAT adjusts item difficulty based on performance. Because the exam is adaptive, there is no fixed number correct or raw percentage that guarantees passing.

ASCP BOC reports MLS performance on a 100 to 999 scaled-score range. The minimum passing score is 400, and it should not be converted to 40%.

The official content areas are Blood Banking, Chemistry, Hematology, Microbiology, Urinalysis and Other Body Fluids, Immunology, and Laboratory Operations.

Official score notification depends on ASCP BOC processing requirements, including transcripts when applicable. Do not rely on informal phone or email score release.

Forward typing tests patient red cells with known antisera. Reverse typing tests patient plasma against known cells. Concordant results support the ABO group.

Rh(D) typing determines whether D antigen is present on red cells. Accurate Rh status is essential for transfusion selection and obstetric risk decisions.

An antibody screen checks patient plasma for unexpected red-cell antibodies. A positive screen requires identification work before compatible blood can be selected.

A crossmatch checks compatibility between recipient plasma and donor red cells. It is not a replacement for correct patient identification, ABO/Rh testing, or antibody investigation.

A direct antiglobulin test detects antibody or complement attached to patient red cells in vivo. It supports investigation of hemolytic transfusion reactions and immune hemolysis.

The immediate safe action is to stop the transfusion and follow facility reaction protocol. Patient safety and clerical check come before completing the unit.

HIL interference can alter chemistry results by affecting analyte concentration, photometric measurement, or specimen quality. Recognize when a result needs review before release.

Sodium, potassium, chloride, and bicarbonate should be interpreted together. Look for specimen issues, acid-base clues, renal status, and whether the value fits the clinical picture.

BUN, creatinine, and estimated filtration markers help assess renal function. Compare current values to prior results and specimen quality before treating an isolated number as final.

ALT and AST suggest hepatocellular injury patterns, while alkaline phosphatase and bilirubin help flag cholestatic or obstructive patterns. The pattern matters more than one isolated enzyme.

Troponin is a key marker of myocardial injury. MLS reasoning includes timing, serial change, analytical interference, and whether the result needs critical-value handling.

TDM results depend on correct specimen timing, dose history, and drug pharmacokinetics. A well-run assay can still mislead if the sample was collected at the wrong point.

Respiratory and metabolic disorders trigger compensatory changes, but compensation rarely overcorrects. Use pH direction, CO2, and bicarbonate together instead of reading one value alone.

Hemoglobin, hematocrit, red-cell indices, white-cell count, platelet count, and smear findings should tell a coherent story. Mismatches call for review or repeat investigation.

MCV helps classify anemia as microcytic, normocytic, or macrocytic. The classification is a starting point, not a diagnosis by itself.

Reticulocytes show marrow response. Increased reticulocytes support blood loss or hemolysis recovery; low reticulocytes suggest inadequate production or marrow suppression.

Blasts on a smear require careful review and escalation according to laboratory policy. Do not release abnormal morphology casually when it may indicate acute leukemia or marrow disease.

Platelets support primary hemostasis and clot plug formation. Coagulation factors support fibrin formation. Bleeding patterns and lab tests differ by which system is affected.

PT evaluates extrinsic and common pathway screening. aPTT evaluates intrinsic and common pathway screening. Prolongation patterns help guide factor, inhibitor, or anticoagulant investigation.

Disseminated intravascular coagulation often shows consumptive coagulopathy patterns such as low platelets, prolonged clotting times, low fibrinogen, and elevated fibrin degradation markers.

A Gram stain gives rapid information about organism type, morphology, and specimen quality. It guides urgency and preliminary thinking, but culture and susceptibility finish the workup.

Mixed flora in a poorly collected specimen may reflect contamination. MLS reasoning compares organism type, site, collection method, quantity, and clinical context.

Biochemical tests identify organisms by metabolic behavior. A single reaction rarely stands alone; identification depends on a pattern that fits organism group and specimen source.

Minimum inhibitory concentration is the lowest antimicrobial concentration that inhibits visible growth under test conditions. Interpretation depends on current breakpoints and organism-drug rules.

A positive blood culture can represent a critical finding. Prioritize Gram stain, timely notification, documentation, and contamination assessment according to lab policy.

Specific gravity reflects urine concentration. Interpret it with hydration status, renal concentrating ability, dipstick findings, and possible interfering substances.

Casts form in renal tubules and can point to renal involvement. Identify cast type carefully because cellular, granular, waxy, and hyaline casts carry different significance.

CSF is time-sensitive and often low volume. Cell count, differential, chemistry, microbiology, and specimen tube order must be handled according to policy and urgency.

Body fluid interpretation depends on source, cell count, differential, appearance, and clinical question. Do not apply urine or blood assumptions automatically to every fluid.

Immunology assays depend on specific antigen-antibody interactions. Sensitivity, specificity, cross-reactivity, timing, and patient immune status affect interpretation.

A negative serologic result can occur before detectable antibody or antigen develops. Timing and clinical context matter when interpreting infectious disease serology.

Autoantibody tests such as ANA are screening or support tools, not standalone diagnoses. Interpret patterns with clinical findings and follow-up testing.

QC monitors whether an analytical system is performing acceptably before patient results are released. Failed QC requires investigation, not silent release.

Levey-Jennings charts show control values over time against the mean and standard deviation limits. They help detect shifts, trends, and random error.

Westgard rules help decide whether control performance suggests random or systematic error. The exam may test the corrective action, not just the rule name.

Calibration establishes the relationship between instrument response and known concentration. QC checks ongoing performance after calibration and during routine testing.

Wrong patient, wrong tube, hemolysis, clotting, delay, temperature error, and poor collection technique can all create bad results before analysis begins.

Critical values require timely notification, read-back or confirmation steps as policy requires, and documentation. Repeating a result does not replace notification policy.

Treat blood and body fluids as potentially infectious. PPE, hand hygiene, sharps safety, and exposure response are core safety expectations in every laboratory domain.

A dilution changes concentration by the dilution factor. Track final volume, specimen volume, and reporting multiplication carefully to avoid a correct assay with a wrong final result.

Conversions require both the numeric factor and the correct direction. Write units through the calculation so the unwanted unit cancels and the reported unit remains.

A delta check compares current and prior patient results. A large unexpected change can signal specimen mix-up, collection issue, clinical change, or analytical problem.

Read the specimen source, patient context, method, result pattern, and policy cue before choosing an answer. The best answer usually resolves the immediate laboratory risk.

After each missed practice question, label the miss by domain and cause: content gap, specimen issue, calculation error, method confusion, or policy sequence error.

Final MLS review should mix domains under time and force explanations. A topic is ready when you can explain the result pattern and reject tempting distractors.